Article
Mutations in the pantothenate kinase of Plasmodium falciparum confer diverse sensitivity profiles to antiplasmodial pantothenate analogues.
PLoS pathogens - 1 Apr 2018
Tjhin Erick T, Spry Christina, Sewell Alan L, Hoegl Annabelle, Barnard Leanne, Sexton Anna E, Siddiqui Ghizal, Howieson Vanessa M, Maier Alexander G, Creek Darren J, Strauss Erick, Marquez Rodolfo, Auclair Karine, Saliba Kevin J
Abstract excerpt
The malaria-causing blood stage of Plasmodium falciparum requires extracellular pantothenate for proliferation. The parasite converts pantothenate into coenzyme A (CoA) via five enzymes, the first being a pantothenate kinase (PfPanK). Multiple antiplasmodial pantothenate analogues, including pantothenol and CJ-15,801, kill the parasite by targeting CoA biosynthesis/utilisation. Their mechanism of action, however,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
